← Open Payments lookup

ROSAIDALIA CARDENAS: Open Payments

NPI 1407420045 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$739 in 33 payments from 12 companies in 2025. Trend: 2023 $15 · 2024 $103 · 2025 $739

Food & beverage: $739
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$160
Teva Pharmaceuticals USA, Inc.5$143
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$82
Janssen Pharmaceuticals, Inc3$76
Neurocrine BioSciences, Inc.2$47
Axsome Therapeutics, Inc.2$43
E.R. Squibb & Sons, L.L.C.2$41
Lundbeck LLC2$40
Takeda Pharmaceuticals U.S.A., Inc.2$38
Tris Pharma Inc1$31

Products named: REXULTI, UZEDY, CAPLYTA, SPRAVATO, INGREZZA, Auvelity, COBENFY, TRINTELLIX.

Industry payments across TX — which companies pay providers there.